G-Tech Medical

What G-Tech Medical does

G-Tech Medical is a privately held, venture-backed medical device company headquartered at the Fogarty Innovation incubator on the El Camino Hospital campus in Mountain View, California. The company has developed GutTracker®, an FDA 510(k)-cleared wireless dermal patch system that continuously monitors myoelectrical signals from the stomach, small intestine, and colon over multiple days. Signals are captured via skin-surface electrode patches, transmitted over Bluetooth to a smartphone application, and forwarded to a secure cloud server where proprietary algorithms — developed from the CTO's particle physics background — assign signals to specific GI organs based on characteristic frequencies (stomach at 3 cpm, small intestine at 8-12 cpm, colon at 12-20 cpm) and generate a per-patient GutPrint® biomarker profile.

The company's primary products are the GutTracker patch system (currently in its Gen 2 form with a three-day battery), the companion smartphone app, and the cloud-based GutPrint® analysis. The platform is positioned as an EKG analog for the gastrointestinal tract and targets gastroenterologists diagnosing functional GI disorders (gastroparesis, IBS, IBD, chronic constipation) as well as surgical departments managing post-operative feeding and discharge decisions. The technology has been validated in 800+ clinical tests across leading US hospitals, supported by 7+ peer-reviewed publications and 30+ conference presentations.

G-Tech generates revenue through the sale of the disposable wireless patches and associated testing services to healthcare providers under physician prescription. The company has stated pricing is not publicly disclosed, consistent with quote-based medical device sales. Go-to-market is direct-to-provider, targeting gastroenterology practices and hospital systems exclusively in the United States. Key clinical partners have included Mayo Clinic (Jacksonville), El Camino Hospital, and the Parkinson's Institute, though these relationships are primarily research-based rather than commercial-customer relationships. The company is funded by DigiTx Partners, Breakout Labs (Thiel Foundation), EMV Capital, and the Kenneth Rainin Foundation, with leadership comprising a CEO (Scott Schorer) with healthcare turnaround and commercialization experience, a CTO/founder (Steve Axelrod, PhD) with physics and medical device backgrounds, and senior clinical and business development staff.

Name

G-Tech Medical

Legal name

G-Tech Medical

Website

https://gtechmedical.com

Company type

Private

Founded year

2011

Operating status

Operating

Headcount range

1–10 employees

Short description

G-Tech Medical is a private, FDA-cleared medical device company that sells the GutTracker wireless dermal patch system for non-invasive, multi-day monitoring of gastrointestinal myoelectric activity. It serves gastroenterologists and surgical departments diagnosing functional GI disorders such as gastroparesis, IBS, IBD, and chronic constipation in the US market.

Ownership category

akta.pro rank

Product category

Gastrointestinal Diagnostic Medical Devices

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Remote Diagnostics & Home Testing Devices (Connected POC/At-Home Diagnostic Readers) (HLAHACAL)

akta.pro secondary industries

General Gastroenterology (HLAKAEAA), Gastroenterology Telemedicine Platforms (HLALAGAE)

Keywords

• Gastrointestinal diagnostic devices
• Wireless medical patches
• Wearable biosensor technology
• GI motility monitoring
• Electrophysiological monitoring devices

Headquarters

HQ city

Mountain View

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Personnel, Operations, Marketing or Sales, Supply Chain, Infrastructure

Revenue model

1. Device and Testing Services: G-Tech Medical sells the GutTracker wireless patch system and associated testing services. The FDA-cleared device consists of wireless patches, a smartphone app, and cloud-based data analysis. The company generates revenue through the sale of patches and related testing services to healthcare providers and patients under physician supervision.
2. Cloud Data Analysis: Proprietary algorithms analyze data in the cloud and provide patient-specific GI function insights. Data is transmitted from patches via Bluetooth to smartphone, then to secure cloud server for processing and physician report generation.

Go-to-market motion2 records

Distribution channels1 record

Marketing channels4 records

Core offering

G-Tech Medical develops and sells the GutTracker® system, an FDA 510(k)-cleared wireless dermal patch that non-invasively monitors myoelectrical signals from the stomach, small intestine, and colon over multiple days. The patches transmit data via Bluetooth to a smartphone app, which forwards the data to a secure cloud server where proprietary algorithms analyze the signals and produce physician reports for diagnosing functional gastrointestinal disorders such as gastroparesis, IBS, IBD, chronic constipation, and post-surgical ileus.

Product overview

G-Tech Medical offers the GutTracker® system as its primary product—a comprehensive wireless dermal patch platform for gastrointestinal diagnostics. The system consists of wearable electrode patches (Gen 2), a smartphone app for Bluetooth data collection, cloud-based proprietary algorithms for signal analysis, and the GutPrint® output visualization. The platform functions analogously to an EKG for the gut, enabling multi-day monitoring of myoelectrical activity across the entire GI tract. The FDA-cleared device supports clinical decision-making for conditions including gastroparesis, Crohn's disease, chronic constipation, and post-operative recovery assessment.

Differentiator

Problem solved

Functional benefit

Brands

• GutTracker: FDA-cleared wireless dermal patch system for monitoring gastrointestinal motility by measuring myoelectrical signals from the stomach, small intestine, and colon over multiple days
• GutPrint

Products and services

• GutTracker® Wireless Patch System FDA-cleared wireless dermal patch system that monitors myoelectrical signals from the stomach, small intestine, and colon over multiple days, providing clinicians with comprehensive GI motility data for diagnosis of functional gastrointestinal disorders. The system consists of wearable electrode patches (Gen 2 with three-day battery life and four bipolar electrode pairs), a Bluetooth-connected smartphone app, and cloud-based proprietary algorithms for signal analysis. Used under physician supervision by gastroenterologists and surgical departments.

Quantifiable outcome

• Outperformed gastric emptying scintigraphy (GES) in identifying patients with abnormal activity in Mayo Clinic study
• +4 more outcomes

Named customers4 records

Segments3 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability4 records

Feature5 records

Partnerships

One partnership is on record.

• Fogarty InnovationcoreStrategic or Co-development PartnerG-Tech Medical is a 'Company in Residence' at Fogarty Innovation, located on the campus of El Camino Hospital in Mountain View, CA. Founded by Dr. Thomas J. Fogarty, an internationally recognized cardiovascular surgeon, inventor and entrepreneur named on over 200 medical device patents, Fogarty Innovation spurs medical device innovation to improve patient care and lower healthcare costs.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Medtronic: Medtronic owns SmartPill (capsule-based GI motility diagnostic) and PillCam (capsule endoscopy), directly competing with G-Tech's wireless patch in GI motility assessment. As the dominant incumbent in GI diagnostics with established reimbursement and physician relationships, Medtronic is the primary competitive threat to GutTracker.
• Hologic: Hologic operates in women's health diagnostics including GI-adjacent imaging and surgical tools. As a large public medtech with established hospital sales infrastructure, Hologic represents a potential strategic acquirer or competitive benchmark for G-Tech's GI diagnostics business.
• Baxter International: Baxter has a significant medical devices and patient monitoring portfolio and serves hospital systems globally. Its patient monitoring business overlaps conceptually with G-Tech's at-home GI monitoring paradigm, and it represents both a competitive incumbent and potential strategic exit path.
• Philips (Royal Philips): Philips has a large connected care and patient monitoring business, plus GI imaging (legacy Philips Medical) capabilities. Its established hospital sales channels and remote patient monitoring infrastructure make it a relevant incumbent and potential strategic acquirer for G-Tech.

Emerging players

• iRhythm Technologies: iRhythm commercialized the Zio wearable cardiac monitoring patch, which uses a similar wearable-patch-plus-cloud-algorithmic-analysis business model to G-Tech. Its successful commercialization validates the wearable diagnostic + cloud paradigm G-Tech is pursuing in GI, and advisor Dr. Uday Kumar co-founded iRhythm.
• Eko Health: Eko builds digital stethoscopes and AI-enabled auscultation devices that capture physiologic signals and apply cloud-based AI diagnostics — the same signal-acquisition-plus-algorithmic-analysis model G-Tech uses for myoelectric GI signals.
• Bodyport: Bodyport develops a connected cardiovascular monitoring platform using a bathroom scale-like device to capture cardiac signals. It shares G-Tech's model of non-invasive, multi-day, at-home physiologic signal capture with cloud-based algorithmic interpretation.
• HeartBeam: HeartBeam develops a wearable, FDA-cleared cardiac monitoring device that captures ECG signals outside the clinical setting and applies cloud analysis. It is comparable in form factor, business model, and regulatory pathway to GutTracker.
• AliveCor: AliveCor's KardiaMobile is an FDA-cleared personal ECG device paired with AI cloud algorithms. It represents the same direct-to-physician / direct-to-patient wearable diagnostic + cloud analysis business model that G-Tech is bringing to GI motility.

Others

• Vivos Therapeutics: While not directly comparable in GI, Vivos is an example of a small FDA-cleared wearable-style medical device company navigating early commercialization — providing a peer benchmarking point for G-Tech's go-to-market trajectory as a small-cap medtech.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

• Xx.com/gtechmedical
• LinkedInlinkedin.com/company/g-tech-medical

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Funding overview

Funding rounds3 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about G-Tech Medical